METHOD FOR SELECTING EFFECTIVE GROUP OF CANCER TREATMENTS COMBINING USE OF THREE AGENTS OF TAXANE-BASED ANTICANCER AGENT, PLATINUM COMPLEX-BASED ANTICANCER AGENT, AND PYRIMIDINE FLUORIDE-BASED ANTICANCER AGENT

摘要

The objective of the present invention is to provide: a method for selecting an effective group of cancer treatments combining the use of the three agents of a taxane-based anticancer agent, a platinum complex-based anticancer agent, and a pyrimidine fluoride-based anticancer agent; and a reagent for predicting the efficacy of a cancer treatment combining the use of the three agents of a taxane-based anticancer agent, a platinum complex-based anticancer agent, and a pyrimidine fluoride-based anticancer agent. The method selects an effective group of cancer treatments combining the use of the three agents of a taxane-based anticancer agent, a platinum complex-based anticancer agent, and a pyrimidine fluoride-based anticancer agent by using as an indicator the amount of expression product of at least one gene selected from the group consisting of PDGFB, PCGF3, CISH, ANXA5, ANTXR2, B4GALT5, PLK2, ATP7B, AM116A, HECA, JMJD2A, STYX, EGR1, AVPI1, and ERLIN1.